NASDAQ: NEUPNeuphoria Therapeutics Revenue
Neuphoria Therapeutics revenue was $10.23M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was -$8.7k, down 100.1% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, NEUP annual revenue was $10.3M, with Infinity% growth year-over-year.
NEUP past revenue growth
How has NEUP's revenue growth performed historically?
Company
N/A
Industry
150.01%
Market
20.37%
NEUP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NEUP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NEUP revenue history
Current Revenue
$10.3M
Current Earnings
-$243.2k
Current Profit Margin
-2.4%
Be the first to know when NEUP announces revenue.
NEUP Revenue History By Year
| NEUP Yearly Revenue | NEUP Revenue | NEUP Change | NEUP Revenue Growth |
|---|---|---|---|
| 2025-06-30 | $10.30M | N/A | N/A |
| 2024-06-30 | $0.00 | N/A | N/A |
| 2023-06-30 | $0.00 | -$183.08k | -100.00% |
| 2022-06-30 | $183.08k | N/A | N/A |
| 2021-06-30 | $0.00 | -$32.18k | -100.00% |
| 2020-06-30 | $32.18k | N/A | N/A |
Neuphoria Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.